Euclidean Capital as of Sept. 30, 2025
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 77.3 | $184M | 2.6M | 71.37 | |
| Ishares Tr Msci India Etf (INDA) | 8.1 | $19M | 370k | 52.06 | |
| Oric Pharmaceuticals (ORIC) | 5.0 | $12M | 989k | 12.00 | |
| Foghorn Therapeutics (FHTX) | 3.2 | $7.7M | 1.6M | 4.89 | |
| Alector (ALEC) | 1.6 | $3.9M | 1.3M | 2.96 | |
| Pmv Pharmaceuticals (PMVP) | 1.5 | $3.7M | 2.6M | 1.40 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 1.1 | $2.7M | 4.1k | 666.18 | |
| Rapt Therapeutics Com New (RAPT) | 0.9 | $2.1M | 82k | 25.79 | |
| Tenaya Therapeutics (TNYA) | 0.7 | $1.6M | 1.0M | 1.62 | |
| Surrozen Com New (SRZN) | 0.5 | $1.1M | 88k | 12.88 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.4k | 171k | 0.02 |
